Quantgene

Principle 8/12
UNIVERSAL DETECTION IS DRIVEN BY SELF-PAYERS

Here is why:

The current healthcare system has little interest in ending cancer: For health insurance plans, universal detection requires too large of an upfront budget in the short term, even if it saves money in the long term. For institutional healthcare investors, early detection threatens hundreds of billions in revenue from late-stage cancer management they currently rely on.

There are only two stakeholders who have a real interest to End Cancer: WE, the patients; and our physicians. This is why Universal Detection has to be paid for by US, the patients; and enabled by our physicians.

Here is the path to Universal Detection for all:

First, the most forward-thinking patients and physicians will implement Universal Detection in their lives.
Second, this group of early adopters will show a significant drop in cancer mortality.
Third, more people will opt-in to pay for their own Universal Detection.
Fourth, the political pressure will mount on Medicare to pay for it.
Fifth, everyone will receive Universal Cancer Detection annually.

The first group of patients will experience universal cancer protection today. The last group will get it 10 to 15 years later. While this is deeply troubling, it is the only way to bring Universal Cancer Protection to All.

The mission of Quantgene after making Universal Detection available today is to advance efficiency, accessibility and performance of Universal Detection as quickly as possible, so the End of Cancer comes sooner for all of us.

Leave your comments below.

Invest in Quantgene: http://LetsEndCancer.com
Universal Cancer Detection. http://DontWait.Life

Principle 4/12
Universal detection has 0% false positives

Here is why:

Traditional cancer screenings use a single test for a single cancer. They generate “false positives” (the test is positive but there is no cancer), which leads to unnecessary procedures and puts healthy patients at risk.

By default, Universal Cancer Detection systems don’t have false positives. They control the whole diagnostics chain and any test that creates a flag for cancer is followed by one that confirms or cancels the flag. If all flags in the chain are positive, a biopsy diagnosis or rules out cancer.

The system automatically minimizes patient risk by recognizing a wide range of data points and intelligently selecting the best next step in the chain.

This paradigm shift from “test” to “system” changes the role of companies that develop screening solutions: instead of being an “outcomes-are-not-my-problem” diagnostics company, they become medical intelligence companies that are accountable for protecting lives.

We will post the 12 Principles of Cancer Detection over the next few days to outline our PATH TO UNIVERSAL DETECTION - and how we get started TODAY.

Comment below and we will respond.

Invest in Quantgene at http://LetsEndCancer.com
Get Universal Detection at http://QXProtection.com